AR

Anjan Reddy Singi Reddy

Active Director Director DIN 08641675
DIN 08641675 First appointment Dec 2019 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Anjan Reddy Singi Reddy

Data last updated:

Anjan Reddy Singi Reddy is a Director at Medvinbio Labs Private Limited (since 2019). The company operates in Pharma.

DIN 08641675
Primary Designation Director
Industry Pharma
First Appointment 17 Dec 2019
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medvinbio Labs Private Limited U74999TG2019PTC137688
Director17 Dec 20192019Active

Board colleagues of Anjan Reddy Singi Reddy

Directorship timeline

Open interactive timeline →
Medvinbio Labs Private Limited
Premium access

Shareholding and investment profile for Anjan Reddy Singi Reddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anjan Reddy Singi Reddy

Anjan Reddy Singi Reddy currently holds 1 directorship: Medvinbio Labs Private Limited (Director, since 17 Dec 2019).

Anjan Reddy Singi Reddy was first appointed on 17 Dec 2019 as Director at Medvinbio Labs Private Limited.

The current boards of Anjan Reddy Singi Reddy's companies include Chaithanya Indupuru (Medvinbio Labs Private Limited), Manoj Kumar Reddy Indupuru (Medvinbio Labs Private Limited), Subhaschandrabose Reddy Bhavanam (Medvinbio Labs Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available